Tsumura & Co represents a set of core values and a corporate philosophy that guide its operations. The company is driven by a commitment to improving public health and promoting the well-being of individuals. Tsumura & Co embraces traditional Japanese medicine, developing high-quality herbal medicines and health-related products. Through continuous research, innovation, and ethical business practices, the company strives to deliver effective and safe healthcare solutions to its customers. Tsumura & Co aims to contribute to society by combining ancient wisdom with modern scientific advancements, ensuring the highest level of product reliability and customer satisfaction.

Tsumura & Co is primarily present in Japan, where the company is headquartered.

Tsumura & Co, a renowned company, has achieved several significant milestones. Over the years, the company has made tremendous progress in various areas. Tsumura & Co has successfully expanded its market presence globally, establishing a strong reputation in the industry. The company has consistently demonstrated its commitment to innovation by developing cutting-edge products and solutions. Tsumura & Co has also focused on sustainable practices, emphasizing environmental responsibility and social impact. With its exceptional performance, Tsumura & Co has received numerous accolades and industry recognition, solidifying its position as a leader in the market.

Tsumura & Co is a Japanese pharmaceutical company founded in 1893 by Sei-ichiro Tsumura. It specializes in developing and manufacturing traditional herbal medicines known as Kampo. With over a century of experience, Tsumura has become a leading provider of high-quality Kampo products, blending traditional knowledge with modern research techniques. The company's commitment to quality and safety has earned them a strong reputation not just in Japan but also internationally. Tsumura & Co continues to expand its product line and invest in research and development to meet the evolving healthcare needs of people worldwide.

Tsumura & Co faces competition from several key players in the market. Some of the main competitors include Kampo Seiyaku, Kracie Holdings, Taisho Pharmaceutical, and Otsuka Pharmaceutical. These companies also operate in the pharmaceutical industry, offering diverse product portfolios and competing for market share. Tsumura & Co strives to differentiate itself through its unique product offerings, innovative research, and strong branding strategies. By closely monitoring its competitors and continuously adapting to market dynamics, Tsumura & Co aims to maintain its position as a top player in the industry.

Tsumura & Co is primarily active in the pharmaceutical and healthcare industries.

The business model of Tsumura & Co is focused on herbal medicine and health products. Headquartered in Japan, Tsumura & Co specializes in the research, development, manufacture, and sale of traditional Chinese medicine (TCM) products. The company aims to contribute to human health and well-being by providing high-quality, safe, and effective natural remedies. Tsumura & Co operates with a commitment to quality control, utilizing advanced technology and scientific research to ensure the efficacy and safety of its products. With a strong emphasis on traditional medicinal knowledge and expertise, Tsumura & Co continues to lead the herbal medicine market, offering solutions for various health concerns globally.

KGV Tsumura & iznosi 22,56.

Koeficijent cijene i prometa Tsumura & iznosi 2,50.

AlleAktien Qualitätsscore za Tsumura & je 5/10.

Promet Tsumura & iznosi 150,85 milijardi JPY.

Dobit Tsumura & iznosi 16,71 milijardi JPY.

Tsumura & Co is a Japanese company specializing in the manufacturing and selling of traditional Chinese medicines (TCM) and health products. It was founded in 1893 and is headquartered in Tokyo, Japan. The company operates in three business areas: TCM products, branded products, and machinery and equipment. TCM products are the core business of Tsumura & Co, with over 300 products based on traditional Chinese medicine books. The company's well-known products include Tianma Gouteng Yin, Tokishigyakukagoshuyushokyoto, and Rikkunshito. These products are intended to improve health and alleviate symptoms of allergies, asthma, digestive problems, and colds. The branded products division includes cosmetics, dietary supplements, and medical devices. Notable Tsumura & Co brands include Milbon, a hair care line, and Kurenaidrink, a collagen and hyaluronic acid supplement. In the machinery and equipment division, the company offers machines and systems for the automated production of TCM products. These devices help streamline and automate the manual manufacturing process. Tsumura & Co aims to promote understanding and acceptance of TCM worldwide. The company collaborates closely with nutritionists, doctors, and scientists to ensure the effectiveness and safety of its products. It also operates its own research institutes and participates in various public-private partnerships. Tsumura & Co is a global company with branches in Asia, Europe, and North America. It exports its products to over 20 countries and has sales and marketing offices in the USA, Europe, and Asia. In its efforts to expand its business and promote the global acceptance of TCM, Tsumura & Co has formed partnerships with other companies in the healthcare sector. It collaborates with major pharmaceutical companies to conduct joint research and development programs and validate the effectiveness of TCM products. Overall, Tsumura & Co offers a wide range of products and services, making it a key player in the TCM industry. The company is dedicated to promoting understanding and acceptance of TCM worldwide and continuously expanding its product lines.

Tsumura & isplaćuje dividendu od 64,00 JPY raspoređenu preko isplata godišnje.

Dividenda za Tsumura & trenutno se ne može izračunati ili tvrtka ne isplaćuje dividendu.

ISIN od Tsumura & je JP3535800001.

WKN od Tsumura & je 866699.

Oznaka burze tvrtke Tsumura & je 4540.T.

U posljednjih 12 mjeseci Tsumura & je isplatio dividendu u iznosu od 118,00 JPY . To odgovara prinosu dividende od oko 2,38 %. Za sljedećih 12 mjeseci Tsumura & će vjerojatno isplatiti dividendu u iznosu od 124,59 JPY.

Trenutni prinos dividende od Tsumura & iznosi 2,38 %.

Tsumura & isplaćuje dividende kvartalno. One se isplaćuju u mjesecima listopad, travanj, listopad, travanj.

Tsumura & je isplatio dividendu svake godine u posljednjih 23 godina.

Za nadolazećih 12 mjeseci očekuje se isplata dividendi u iznosu od 124,59 JPY. To odgovara dividendnom prinosu od 2,51 %.

Tsumura & se pripisuje sektoru 'Zdravlje'.

Da bi primili posljednju dividendu od Tsumura & od 01. 12. 2024. u iznosu od 68 JPY, trebali ste imati dionicu u portfelju prije Ex-dana 27. 09. 2024..

Posljednja isplata dividende izvršena je 01. 12. 2024..

U godini 2023 su od Tsumura & 67 JPY isplaćene kao dividende.

Dividende od Tsumura & isplaćuju se u JPY.